新一轮中概股回港潮，既是企业对冲外部风险的战略选择，也是香港资本市场深化改革开放的重要机遇。随着文远知行、小马智行、天境生物等新经济公 司相继启动回归及上市程序，港股市场正迎来更多优质投资标的。而对于中国企业而言，回港上市不仅意味着融资渠道的多元化，更是其在全球市场稳健 前行的重要一步。 10月17日，生物科技公司天境生物公告称将回归香港实现双重主要上市；10月14日，智能驾驶领域的文远知行、小马智行相继通过中国证监会境外上市备 案，正式启动港股上市流程，其中小马智行已通过港交所上市聆讯。分析认为，此次回归潮由技术密集型的新经济公司领衔，或将完善港股市场生态。 ...

Group 1 - The Hong Kong IPO market is experiencing a significant surge, with fundraising exceeding 1,050 billion HKD as of June 30, making it the leading global capital market [1][2] - The number of IPOs in Hong Kong has increased, with 42 IPOs completed in the first half of the year, raising over 1,070 billion HKD, which is approximately 22% more than the total for the previous year [2] - The presence of mainland companies in the Hong Kong market has grown, with over 2,600 listed companies, 81% of which are from mainland China, highlighting Hong Kong's role as a gateway for these companies [2] Group 2 - The introduction of the "dual-class share" structure in April 2018 has led to a rise in new economy companies listing in Hong Kong, contributing to the overall increase in IPO activity [2] - The financial inflow into Hong Kong has reached a record high, increasing from 3,660 billion USD in early 2024 to 5,060 billion USD by April 2025, indicating a robust capital market [3] - The Hong Kong Stock Exchange has customized a larger gong for simultaneous listings, reflecting the growing number of companies seeking to go public [2]